MonTa Biosciences ApS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MonTa Biosciences ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11109
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MonTa Biosciences ApS (MonTa Biosciences) is a biotechnology company that develops and commercializes immuno-oncology therapeutics for cancer therapy. Its pipeline products include MBS2, and MBS5 used for the treatment of cancer and infectious diseases. The company’s technology is based on TLR7 agonist that stimulates antitumor activity by specific formulations targeting the intracellular TLR7 receptor in major immune cells such as monocytes, dendritic cells and macrophages. Its technology also complements existing therapies like radiation, chemotherapy, therapeutic antibodies and immune checkpoint inhibitors by boosting the immune system. The company is a spin off from DTU Nanotech. MonTa Biosciences is headquartered in Copenhagen, Denmark.

MonTa Biosciences ApS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MonTa Biosciences ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MonTa BioSciences Raises USD0.3 Million in Seed Financing 10
Licensing Agreements 11
MonTa Biosciences Enters into Licensing Agreement with University of California and Technical University of Denmark 11
Equity Offering 12
MonTa Biosciences Spin Out from Technical University of Denmark 12
MonTa Biosciences ApS – Key Competitors 13
MonTa Biosciences ApS – Key Employees 14
MonTa Biosciences ApS – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Other Significant Developments 16
Mar 10, 2017: MonTa BioSciences raises investment for promising cancer treatment 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Key Facts 2
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MonTa Biosciences ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MonTa Biosciences ApS, Deals By Therapy Area, 2012 to YTD 2018 8
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MonTa BioSciences Raises USD0.3 Million in Seed Financing 10
MonTa Biosciences Enters into Licensing Agreement with University of California and Technical University of Denmark 11
MonTa Biosciences Spin Out from Technical University of Denmark 12
MonTa Biosciences ApS, Key Competitors 13
MonTa Biosciences ApS, Key Employees 14

List of Figures
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MonTa Biosciences ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MonTa Biosciences ApS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Secom Co Ltd.:企業の戦略・SWOT・財務分析
    Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Carnival Group International Holdings Ltd:企業のM&A・事業提携・投資動向
    Carnival Group International Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carnival Group International Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Cytox Ltd-医療機器分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報
    Summary Spire Inc (Spire), formerly Laclede Group, Inc., is a public utility, which carries out the sale, marketing and retail distribution of natural gas. It also markets natural gas and related activities on a non-regulated basis. The company also conducts transportation of liquid propane; real es …
  • Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers t …
  • Provogue (India) Limited (PROVOGE):企業の財務・戦略的SWOT分析
    Provogue (India) Limited (PROVOGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bina Puri Holdings Bhd:企業の戦略・SWOT・財務情報
    Bina Puri Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Bina Puri Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sturm, Ruger & Company, Inc.:戦略・SWOT・企業財務分析
    Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Puma SE (PUM):企業の財務・戦略的SWOT分析
    Puma SE (PUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Curetis NV (CURE):企業の財務・戦略的SWOT分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue inf …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise value hearing health, biomedical solutions, hearing health manufacturing and professional audio. In addition it also …
  • Hanwha Life Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The Israel Electric Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary The Israel Electric Corporation Ltd (IECL) formerly Palestine Electric Corporation Ltd., is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …
  • Parker Institute for Cancer Immunotherapy:製薬・医療:M&Aディール及び事業提携情報
    Summary Parker Institute for Cancer Immunotherapy (Parker Institute), a subsidiary of The Parker Foundation is a nonprofit public benefit corporation which focuses on the development of immune therapies for the treatment of cancer. The institute coordinates together the scientists, nonprofits, acade …
  • Dewan Housing Finance Corporation Limited:企業のM&A・事業提携・投資動向
    Dewan Housing Finance Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dewan Housing Finance Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. The company offers software engineering of computer based electrocardiogram management and reporting software. …
  • Synchronoss Technologies, Inc. (SNCR):企業の戦略的SWOT分析
    Synchronoss Technologies, Inc. (SNCR) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Dance Biopharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務分析
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆